Eusol   Report issue

For profit Phase 2 Phase 3
Founded: Taipei Taiwan (2005)

Organization Overview

First Clinical Trial
2016
NCT02671760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Eusol Biotech Co., Ltd.